Cat Therapeutic Diet Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Wet Food, Dry Food), By Indication (Renal Care, Obesity Care, Diabetic Care, Dental Care), By Distribution Channel, By Region, And Segment Forecasts

Cat Therapeutic Diet Market Summary

The global cat therapeutic diet market size was estimated at USD 1.8 billion in 2025 and is projected to reach USD 3.6 billion by 2033, growing at a CAGR of 8.9% from 2026 to 2033. The market growth is driven by continuous innovation in specialized pet nutrition, enabling the development of more effective and condition-specific formulations.

This is further supported by the rising prevalence of chronic diseases in cats, which is increasing the need for targeted dietary interventions. In addition, the ongoing premiumization of pet food products, with a shift toward high-quality, scientifically formulated diets, is also contributing significantly to overall market expansion. 

Advancements in microbiome science are playing a critical role in transforming therapeutic nutrition for pets, with leading companies introducing clinically backed innovations. For instance, Hill's Pet Nutrition showcased its latest developments at the Veterinary Meeting & Expo (VMX) 2025, highlighting new and enhanced Prescription Diet and Science Diet products powered by ActivBiome+ technology. This innovation is based on extensive microbiome research involving thousands of biological samples, enabling targeted nutritional interventions that actively support gut health. The technology includes specialized formulations such as ActivBiome+ Digestion for gastrointestinal support, ActivBiome+ Kidney Defense for reducing toxin buildup, and Multi-Benefit blends designed to enhance immune and organ health.

Moreover, the increasing prevalence of chronic and nutrition-related diseases in cats is significantly driving the demand for specialized dietary interventions. For instance, according to an article published by SKS Veterinary Hospital, in October 2025, among the conditions, obesity has emerged as one of the most common and clinically complex disorders in companion animals, particularly in urban environments where prevalence rates are estimated to reach 35-40%. Beyond excess weight, obesity is associated with metabolic dysfunction, hormonal imbalance, and a higher risk of secondary conditions such as diabetes, joint disorders, and cardiovascular complications. Although adoption is still evolving, there is a growing opportunity for clinically formulated weight-management diets, with around 35% of cat owners already incorporating therapeutic or prescription diets into their pets’ weight-loss programs.

Moreover, according to an article published by Merck & Co., Inc., diabetes is an increasingly recognized metabolic disorder in pets, affecting approximately 1 in 230 cats. This growing prevalence highlights the need for early diagnosis and structured disease management, as diabetes requires long-term control through a combination of veterinary care and specialized nutrition. This gap between disease prevalence and treatment adoption highlights a strong growth potential for the cat therapeutic diet industry. As veterinary awareness and diagnostic rates improve, there is a growing shift toward structured, diet-based management of obesity and its related conditions.

Furthermore, the increasing adoption of pet insurance is creating a strong opportunity for the cat therapeutic diet industry by improving affordability and encouraging veterinary-led treatment. For instance, policies offered through Asda Money cover veterinary consultations, diagnostics, medications, and treatments for new illnesses or injuries, which increases the likelihood of early diagnosis and clinical intervention. Importantly, these policies also include specialist or prescribed diet food under veterinary fee cover, typically within defined limits depending on the plan. This means that for conditions like GI issues, renal disease, or allergies, a portion of the cost of therapeutic or prescription diets may be covered as part of treatment, easing the financial burden on pet owners.

Market Characteristics & Concentration

The cat therapeutic diet industry is consolidated, with a limited number of prominent players maintaining a stronghold through well-established brands, robust veterinary relationships, and ongoing advancements in specialized nutrition. These companies leverage extensive distribution networks and clinical credibility, making it challenging for new entrants to gain a foothold in the market. Moreover, the cat therapeutic diet industry is experiencing faster growth, driven by increasing pet humanization and greater recognition of targeted nutritional therapies. The influence of veterinarians remains pivotal, as cat owners are increasingly seeking professional advice for disease management, thereby supporting the demand for clinically backed therapeutic diets.

The cat therapeutic diet industry demonstrates strong innovation, with companies consistently introducing advanced, condition-specific nutritional solutions. Focus areas include microbiome-based formulations, functional ingredients, and precision nutrition tailored to specific feline health conditions such as renal disorders, obesity, and gastrointestinal issues. Continuous investment in research and clinical validation is enhancing product efficacy and credibility.

Merger and acquisition activity in the cat therapeutic diet industry is gaining momentum as companies seek to strengthen their competitive positioning. Leading players are acquiring smaller, specialized firms to expand their therapeutic portfolios and access novel technologies or formulations. These strategic moves also enable companies to enhance their global footprint and enter new geographic markets more efficiently.

Regulatory frameworks have a significant influence on the cat therapeutic diet industry, particularly regarding product safety, labeling, and clinical claims. Strict guidelines ensure that therapeutic diets meet specific nutritional and medical standards, thereby increasing trust among veterinarians and pet owners. However, compliance with these regulations can be complex and resource-intensive, especially for new entrants. Regulatory approvals may also extend product development timelines, impacting speed to market. Despite these challenges, well-defined regulations help maintain high product quality and industry credibility.

The presence of product substitutes such as homemade diets and conventional pet food poses a moderate challenge to the market. However, these alternatives often lack the clinical validation and targeted nutritional balance needed to manage specific health conditions in cats. Therapeutic diets recommended by veterinarians continue to dominate due to their proven effectiveness and reliability. In addition, increasing awareness about the risks of improper nutrition is reducing reliance on unverified substitutes. As a result, the impact of substitutes remains limited, particularly in cases involving chronic or severe health conditions.

Regional expansion remains a critical growth strategy in the cat therapeutic diet industry, as companies aim to tap into emerging markets with rising pet ownership. Increasing urbanization, improving veterinary infrastructure, and growing awareness of pet health are creating new opportunities in regions such as Asia-Pacific, Latin America, and the Middle East. Companies are expanding their distribution networks through e-commerce platforms, veterinary clinics, and specialty pet stores to improve accessibility.

Product Insights

The dry food segment led the market with the largest revenue share of 66.81% in 2025 and is anticipated to grow at the fastest CAGR over the forecast period, driven by ongoing innovations and product launches in the segment. For instance, in April 2025, Hill's Pet Nutrition enhanced its Science Diet adult and senior dry pet food range by incorporating advanced microbiome technology, specifically through its ActivBiome+ Multi-Benefit formulation, which combines a precise blend of prebiotic fibers and antioxidants to promote overall health. This innovation is designed to support a balanced gut microbiome, which plays a critical role in digestion, nutrient absorption, immune function, and organ health, particularly in aging pets that are more prone to digestive and metabolic issues. By integrating multi-functional health benefits into everyday dry kibble, the company is strengthening the role of preventive nutrition, making therapeutic-like benefits more accessible in routine diets while also improving long-term pet wellness and dietary effectiveness.

The wet food segment is expected to witness at a significant CAGR during the forecast period, owing to the growing emphasis on improving pet diet compliance through enhanced palatability and multi-condition therapeutic formulations. For instance, in January 2024, Hill's Pet Nutrition launched new products and enhancements to its Prescription Diet line ahead of NAVC’s VMX 2024, introducing solutions such as z/d Low Fat Hydrolyzed Soy Canine, c/d Multicare Low Fat Canine, Gastrointestinal Biome Stress Feline, and new wet flavors under c/d Multicare Stress Feline. This initiative also highlights the company’s focus on addressing multiple conditions through a single diet, improving convenience for pet owners and veterinarians.

Indication Insights

The obesity care segment accounted for the largest market revenue share in 2025, driven by the increasing incidence of obesity among cats, coupled with a heightened focus on feline health and wellness. Simultaneously, strategic initiatives undertaken by key industry players are further accelerating growth by strengthening product innovation and market penetration. For instance, in February 2025, Colgate-Palmolive Company (Hill’s Pet Nutrition) entered into a collaboration with APOP to deliver data-driven strategies, aimed at enhancing the development and positioning of scientifically validated weight management diets. This collaboration is expected to accelerate the adoption of clinically proven nutritional solutions while strengthening the overall demand for precision-driven, research-backed approaches in feline health management.

The renal care segment is anticipated to grow at the fastest CAGR over the forecast period, driven by innovations in therapeutic nutrition formats that enhance compliance and effectiveness, thereby propelling market growth. For instance, in September 2025, Virbac introduced Vikaly, the first medicated renal feed for cats, combining diet with pharmaceuticals. This shift toward integrated nutrition-therapy solutions is enabling more precise disease management while reducing reliance on standalone medications. In addition, advancements in formulation technologies and ingredient customization are supporting condition-specific dietary interventions, further strengthening clinical outcomes. As a result, both veterinarians and pet owners are increasingly adopting these advanced therapeutic diets as part of comprehensive treatment regimens.

Distribution Channel Insights

The veterinary hospitals & clinics segment accounted for the largest market revenue share in 2025. Improved access to veterinary care and the expansion of networks of animal hospitals and clinics, especially in urban and suburban areas, help in strengthening the segment growth. Many clinics offer in‑house nutrition counseling, customized diet plans, and ongoing follow‑up, which support the trust owners place in these products and also increase repeat purchase and compliance rates. Veterinarians also educate owners about the benefits and appropriate use of therapeutic diets, helping overcome barriers such as misconceptions about cost or efficacy.

The e-commerce segment is anticipated to grow at the fastest CAGR over the forecast period. The rapid expansion of e-commerce platforms is significantly driving market growth by improving accessibility, convenience, and product visibility for pet owners. Online channels enable a wide range of therapeutic diets, supplements, and condition-specific products to be easily compared, reviewed, and purchased without geographical limitations, encouraging informed decision-making. Subscription-based models and auto-replenishment services further support consistent adherence to prescribed therapeutic regimens, particularly for chronic conditions such as obesity, renal disorders, and gastrointestinal issues in cats.

Regional Insights

North America dominated the global cat therapeutic diet market with the largest revenue share of 37.08% in 2025. The market growth is supported by high pet insurance penetration, advanced veterinary care systems, and continuous product innovation and new therapeutic formulations introduced by major pet food companies. Furthermore, the growth of e-commerce and veterinary distribution channels has improved the availability of prescription diets, further supporting market expansion across North America. In addition, increasing pet humanization and the willingness of owners to invest in premium, condition-specific nutrition are further strengthening demand. The strong presence of established market players, coupled with ongoing investments in research and development, is accelerating the introduction of scientifically validated therapeutic solutions.

U.S. Cat Therapeutic Diet Market Trends

The cat therapeutic diet market in the U.S. accounted for the largest market revenue share in North America in 2025. New product launches, collaborations, and business expansions are significantly driving growth in the U.S. market by increasing product innovation, advancing veterinary nutrition research, and expanding product availability across distribution channels. Major companies continuously launch new therapeutic diet formulations focused on gut health, weight management, and disease-specific nutrition, which increases product adoption and market expansion.

The Mexican cat therapeutic diet market is expected to grow at a significant CAGR over the forecast period, driven by the increasing number of households owning cats in urban areas. As pet ownership increases, spending on pet healthcare, veterinary services, and specialized pet food products such as therapeutic diets also increases. Pet owners are willing to spend on premium and disease-specific pet food products that support disease management and overall pet health. The expansion of veterinary clinics and pet healthcare services in Mexico is also supporting the market growth

Europe Cat Therapeutic Diet Market Trends

The cat therapeutic diet market in Europe is growing, driven by rising cat ownership. As more households adopt cats, owners are focused on maintaining their pets’ health and quality of life. This trend has led to greater demand for specialized diets that prevent or manage chronic conditions, and products recommended by veterinarians. The combination of more pets, heightened health awareness, and willingness to invest in nutrition ensures continued expansion of the therapeutic diet segment across European markets.

The UK cat therapeutic diet market is expanding, due to the strong veterinary infrastructure and high pet insurance adoption in the UK, which supports the use of prescription diets recommended by veterinarians. The market is also benefiting from the expansion of e-commerce and specialty pet retailers, making therapeutic diets more accessible to pet owners across the country. Moreover, the broader UK pet food market is shifting toward premium, health-focused, and functional nutrition products, which supports the growth of therapeutic diets as pet owners are willing to spend more on specialized nutrition for their pets’ health and longevity.

The cat therapeutic diet market in Franceis anticipated to grow swiftly, as pet owners place greater emphasis on the health and overall well-being of their animals. There is a rising trend toward using specialized therapeutic diets to manage chronic health issues in cats, such as digestive disorders, skin sensitivities, and obesity, with veterinarians recommending these products as part of treatment plans. This shift is supported by the strong humanization of pets in French households, where owners are willing to spend more on high‑quality, condition‑specific nutrition.

Asia Pacific Cat Therapeutic Diet Market Trends

The cat therapeutic diet market in the Asia Pacific is expected to grow at the fastest CAGR over the forecast period. The expansion of distribution channels has boosted the adoption of cat therapeutic food. E-commerce platforms, tele-veterinary services, and enhanced retail networks have made therapeutic diets more accessible, even in smaller cities. Online platforms also provide owners with convenient opportunities to research, purchase, and regularly replenish specialized diets. Moreover, improved veterinary healthcare infrastructure in the region has further contributed to the market growth.

The China cat therapeutic diet market held the significant share in the Asia Pacific in 2025,driven by shifting consumer preferences and deeper emotional bonds between owners and their pets. For instance, 85 % of pet owners consider their pets as part of the family. Spending on pet-related products on major e‑commerce platforms like JD.com has surged, with pet product purchases jumping more than 2.1 times year‑on‑year during major sales events, indicating strong consumer demand and engagement in the sector.

The cat therapeutic diet market in Japan is gaining strong momentum, supported by premiumization trends, with pet owners willing to invest in high-quality, scientifically formulated products that contain functional ingredients such as prebiotics, antioxidants, and joint-support nutrients. Enhanced distribution channels, including e-commerce platforms, pet specialty stores, and veterinary clinics, have made these products more accessible across urban and suburban areas, further driving market penetration.

Latin America Cat Therapeutic Diet Market Trends

The cat therapeutic diet market in Latin America is driven by the presence of untapped market opportunities, improving economic conditions, and growing awareness among pet owners regarding preventive healthcare. Moreover, in 2025, several prominent companies undertook strategic initiatives to strengthen their footprint in the region and enhance animal healthcare solutions. For instance, in March 2025, companies such as IPB, Nutritech, Panelaço, Tratyvet, and PetSociety participated in initiatives to promote Brazilian pet businesses in international markets.

The Argentina cat therapeutic diet market benefits from the strong resilience of pet food demand despite economic volatility. Even as inflation pressures and lower disposable incomes impact spending, pet owners continue to prioritize pet nutrition, adapting their buying behavior instead of reducing overall consumption. This behavior supports consistent demand for both standard and therapeutic diets, especially for pets requiring long-term nutritional management.

Middle East & Africa Cat Therapeutic Diet Market Trends

The cat therapeutic diet market in the Middle East & Africa is driven by stronger regulatory oversight and rising pet health awareness. Veterinarians are incorporating therapeutic and prescription diets into routine treatment plans to manage chronic conditions such as gastrointestinal disorders, kidney disease, obesity, and food allergies, while also supporting immunity and long-term disease management. This shift is partly driven by growing concerns about antimicrobial resistance, which are encouraging preventive healthcare approaches through nutrition rather than medication alone.

The South Africa cat therapeutic diet marketis strengthened by the rapid proliferation of veterinary clinics, specialized pet retail outlets, and premium pet food brands across key urban centers such as Johannesburg, Cape Town, and Durban. This expanding infrastructure is enhancing access to advanced pet healthcare products and services, while also supporting the growing availability of high-quality, condition-specific nutrition. As a result, improved distribution networks and increased consumer exposure to premium offerings are collectively driving sustained market development in these metropolitan regions.

The cat therapeutic diet market in the UAEis propelled by the rapid expansion of e-commerce and online pet food sales, which are significantly enhancing product accessibility and purchasing convenience for pet owners. In addition, urban centers such as Kuwait City serve as key market hubs, supported by higher pet ownership rates and well-established access to veterinary clinics and specialized pet retail outlets, thereby contributing to stronger market growth. Rising pet population, premium pet food demand, increasing veterinary recommendations, and growing awareness of disease-specific nutrition are key factors driving the market growth in Kuwait. For instance, international pet nutrition companies such as Hill's Pet Nutrition, Royal Canin, and Nestlé Purina PetCare distribute veterinary therapeutic diets in Kuwait through veterinary clinics, pet hospitals, and specialty pet stores, increasing product availability in the country.

Key Cat Therapeutic Diet Company Insights

The cat therapeutic industry is characterized by intense competition, with leading global companies striving to strengthen their positions through scientifically validated formulations, continuous innovation, and strong brand credibility. Market participants are increasingly focusing on developing targeted, condition-specific diets tailored to feline health concerns such as renal disorders, obesity, and gastrointestinal issues to create clear differentiation.

Competition is particularly pronounced in gaining the trust of veterinarians and securing endorsements through clinical evidence and partnerships with veterinary clinics and hospitals. In addition, companies are investing heavily in educational initiatives, awareness campaigns, and digital platforms to engage pet owners and influence purchasing decisions.

Recent Developments

• In January 2026,Royal Canin introduced GLYCOADVANCED, a feline therapeutic diet targeting diabetic and overweight cats. Such launches bolster disease-specific nutrition offerings, particularly in metabolic and endocrine care, driving growth in specialized veterinary diet segments.

• In September 2025, Virbac launched Vikaly, the world’s first medicated cat food combining renal kibble with a regulated veterinary drug. Such breakthroughs create a new therapeutic model, improve treatment compliance, and establish a novel category in prescription-based pet therapeutic diets.

• In July 2025, Nestlé Purina expanded its Friskies line in India with Meaty Grills and Indoor Delights, targeting diverse feline nutritional needs such as hairball control. Such initiatives strengthen affordable therapeutic-adjacent nutrition, boosting penetration in emerging markets and increasing demand for functional cat diets.

• In November 2025, Farmina partnered with MyVetStoreOnline to enable home delivery of VetLife therapeutic diets. This improves treatment adherence and convenience for pet owners, supporting the growing trend of digital veterinary care.

Cat Therapeutic Diet Market Report Scope

Global Cat Therapeutic Diet Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cat therapeutic diet market report based on product, indication, distribution channel, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Wet Food

  • Dry Food

  • Others

• Indication Outlook (Revenue, USD Million, 2021 - 2033)

  • Renal Care

  • Obesity Care

  • Diabetic Care

  • Dental Care

  • Gastrointestinal Care

  • Recovery Care

  • Joint Care

  • Oncology Care

  • Others

• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

  • E-commerce

  • Veterinary hospitals & clinics

  • Retail Pharmacies

  • Others

• Region Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • UAE

    • Saudi Arabia

    • Kuwait

    • Qatar

    • Oman